MEFV and inflammatory bowel disease: More than half of the IBD patients with MEFV mutations (20 of 37; 54.0%) had heterozygous genotypes, 12 (32.4%) had compound heterozygous genotypes, and 5 (13.5%) had homozygotes (Table 3).